SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-050418
Filing Date
2017-08-28
Accepted
2017-08-28 16:42:59
Documents
2
Period of Report
2017-08-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1602
2 EX-24 DOCUMENT attachment1.htm EX-24 4261
  Complete submission text file 0001209191-17-050418.txt   7266
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Issuer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DIMENSION THERAPEUTICS, INC. 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address
Franchi Jean M. (Reporting) CIK: 0001653053 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35409 | Film No.: 171055033